Literature DB >> 17525649

Long-term outcome in ocular intractable surface disease with Seoul-type keratoprosthesis.

Mee Kum Kim1, Sang Mok Lee, Jae Lim Lee, Tae Young Chung, Young Ha Kim, Won Ryang Wee, Jin Hak Lee.   

Abstract

PURPOSE: To evaluate the long-term clinical efficacy of the Seoul-type keratoprosthesis (S-KPro).
METHODS: S-KPros were implanted into 4 unsighted and 5 sighted eyes in 9 patients: 6 patients were diagnosed with Stevens-Johnson syndrome, 2 had chemical burns, and 1 suffered from ocular pemphigoid. The preoperative visual acuity ranged from light perception to hand motion. The average follow-up period was 62.8 months. We evaluated several clinical factors, including visual acuity, visual field, number of additional grafting procedures, number of capsulotomy procedures, and the interval between retinal detachment and skirt exposure.
RESULTS: The S-KPro showed anatomic success for an average of 62.8 months in 66.7% of the eyes. The average visual acuity preservation time was 31.6 months. Localized glaucomatous visual field defect was not found in any of the sighted patients; however, diffuse visual field constriction was observed after long-term follow-up. Average time of skirt exposure and mean number of additional grafting procedures were 12.9 months and 2.44, respectively. Retinal detachments were developed in all the patients at a mean time interval of 2 months after S-KPro exchange.
CONCLUSIONS: S-KPro achieved visual rehabilitation for an average of 31.6 months with long-term anatomic stability in patients with severe intractable ocular surface disease.

Entities:  

Mesh:

Year:  2007        PMID: 17525649     DOI: 10.1097/ICO.0b013e3180415d35

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  4 in total

1.  Matrix metalloproteinase-9 expression in the Seoul-type keratoprosthesis implanted corneas with concurrent cultivated autologous oral mucosal epithelial cell transplantation.

Authors:  Sang-Mok Lee; Mee-Kum Kim; Mi-Sun Shin; Won-Ryang Wee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-18       Impact factor: 3.117

2.  Implantation of Iakymenko keratoprosthesis in patients with severe ocular injury.

Authors:  Hong-Wei Pan; Stanislav Iakymenko; Jin-Tang Xu; Guang-Hui Hou; Bing-Ji Sun; A-Ning Zheng
Journal:  Int J Ophthalmol       Date:  2012-04-18       Impact factor: 1.779

Review 3.  A Review of the Diagnosis and Treatment of Limbal Stem Cell Deficiency.

Authors:  Anahita Kate; Sayan Basu
Journal:  Front Med (Lausanne)       Date:  2022-05-25

Review 4.  Keratoprostheses for corneal blindness: a review of contemporary devices.

Authors:  Venkata S Avadhanam; Helen E Smith; Christopher Liu
Journal:  Clin Ophthalmol       Date:  2015-04-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.